Cellectar Biosciences, Inc. (CLRB)
NASDAQ: CLRB · Real-Time Price · USD
0.3021
+0.0101 (3.46%)
At close: Apr 2, 2025, 4:00 PM
0.3014
-0.0007 (-0.24%)
After-hours: Apr 2, 2025, 7:51 PM EDT

Cellectar Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
141234164194
Upgrade
Market Cap Growth
-63.75%-63.75%112.09%-60.44%-57.05%346.76%
Upgrade
Enterprise Value
-9-635-0277
Upgrade
Last Close Price
0.290.302.771.716.6420.80
Upgrade
PB Ratio
0.980.79-2.471.681.231.72
Upgrade
P/TBV Ratio
0.900.90-1.971.282.72
Upgrade
Debt / Equity Ratio
0.030.03-0.040.060.010.01
Upgrade
Quick Ratio
2.482.480.381.738.9516.04
Upgrade
Current Ratio
2.582.580.411.799.1616.26
Upgrade
Return on Equity (ROE)
-4693.38%-4693.38%--149.33%-54.92%-47.28%
Upgrade
Return on Assets (ROA)
-172.36%-172.36%-144.66%-61.26%-31.47%-26.95%
Upgrade
Return on Capital (ROIC)
-2196.39%-2196.39%--82.83%-34.06%-29.49%
Upgrade
Earnings Yield
-319.51%-361.28%-125.65%-198.10%-59.46%-15.98%
Upgrade
FCF Yield
-341.77%-386.45%-97.66%-158.57%-55.98%-14.82%
Upgrade
Buyback Yield / Dilution
-203.92%-203.92%-73.22%-27.09%-180.20%-158.14%
Upgrade
Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q